A Study on Visco-antalgic Intra-articular Administration in Symptomatic Knee Osteoarthritis
A Two-stage 6-month Multicentre, Randomised, Double-blind, Controlled Study on the Safety and Efficacy Intra-articular Administration of JTA-004 in Patients With Symptomatic Knee Osteoarthritis
Sponsor: Bone Therapeutics S.A
A PHASE2/PHASE3 clinical study on Knee Osteoarthritis, this trial is completed. The trial is conducted by Bone Therapeutics S.A and has accumulated 11 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2022 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Jan 2022 [monthly]
Completed PHASE2_PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 6 earlier versions
-
Nov 2018 — Jul 2020 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Sep 2017 — Dec 2017 [monthly]
Recruiting PHASE2_PHASE3
-
Feb 2017 — Sep 2017 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bone Therapeutics S.A
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.